Dr. Reddy's Laboratories Limited has announced that the audit of its formulations manufacturing facilities (FTO 7 & FTO 9) at Duwada, Visakhapatnam, by the US FDA, has been completed and the company has been issued a Form 483 with 8 (eight) observations, which we will address within the stipulated timeline.
Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 4800.55 as compared to the previous close of Rs. 4670.05. The total number of shares traded during the day was 29306 in over 4507 trades.
The stock hit an intraday high of Rs. 4835.00 and intraday low of 4630.20. The net turnover during the day was Rs. 139685056.00.